Where Tantech stands after its latest Filing
Revenue for the twelve months was $38m, down 10.7% on a year earlier, a steeper fall than the 3.8% decline a quarter earlier. That puts it 35 of 42 for growth among the specialty chemicals companies we cover. Free-cash-flow margin held at -15.2%. Operating margin narrowed to -31.8% from -15.4%. The diluted share count is up 444.4% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades E. It passes 2 of our 3 financial-health checks. Our cash-flow model value is $27.66 a share, against a share price of $12.28.